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Background: Theiler’s murine encephalomyelitis virus (TMEV) infection represents a commonly used infectious animal
model to study various aspects of the pathogenesis of multiple sclerosis (MS). In susceptible SJL mice, dominant activity
of Foxp3+ CD4+ regulatory T cells (Tregs) in the CNS partly contributes to viral persistence and progressive
demyelination. On the other hand, resistant C57BL/6 mice rapidly clear the virus by mounting a strong antiviral
immune response. However, very little is known about the role of Tregs in regulating antiviral responses during
acute encephalitis in resistant mouse strains.
Methods: In this study, we used DEREG mice that express the diphtheria toxin (DT) receptor under control of the
foxp3 locus to selectively deplete Foxp3+ Tregs by injection of DT prior to infection and studied the effect of Treg
depletion on the course of acute Theiler’s murine encephalomyelitis (TME).
Results: As expected, DEREG mice that are on a C57BL/6 background were resistant to TMEV infection and cleared the
virus within days of infection, regardless of the presence or absence of Tregs. Nevertheless, in the absence of Tregs we
observed priming of stronger effector T cell responses in the periphery, which subsequently resulted in a transient
increase in the frequency of IFNγ-producing T cells in the brain at an early stage of infection. Histological and
flow cytometric analysis revealed that this transiently increased frequency of brain-infiltrating IFNγ-producing T
cells in Treg-depleted mice neither led to an augmented antiviral response nor enhanced inflammation-mediated
tissue damage. Intriguingly, Treg depletion did not change the expression of IL-10 in the infected brain, which
might play a role for dampening the inflammatory damage caused by the increased number of effector T cells.
Conclusion: We therefore propose that unlike susceptible mice strains, interfering with the Treg compartment of
resistant mice only has negligible effects on virus-induced pathologies in the CNS. Furthermore, in the absence of
Tregs, local anti-inflammatory mechanisms might limit the extent of damage caused by strong anti-viral response
in the CNS.
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Multiple sclerosis (MS), one of the most frequent cen-
tral nervous system (CNS) diseases in young adults, is a
chronic demyelinating disease of unknown etiology and
probably multifactorial causes. Based on the generation
of myelin-specific immune responses, MS is regarded
as an autoimmune disease [1,2], possibly triggered by
virus infections [3,4]. Due to clinical and pathological
similarities, Theiler’s murine encephalomyelitis (TME)
represents a commonly used infectious animal model
for the chronic-progressive form of MS in humans [5].
Here, intracerebral infection of mice with the low virulent
BeAn-strain of the Theiler’s murine encephalomyelitis
virus (TMEV) causes an acute transient polioencephali-
tis [6], characterized by the infiltration of virus-specific
lymphocytes [7]. Inadequate viral clearance in SJL mice
leads to persistent infection of the CNS and immune-
mediated spinal cord demyelination [6,8-10]. In contrast,
resistant C57BL/6 mice eliminate the virus from the CNS
by specific cellular immunity, including effective CD4+
and CD8+ T cell responses during the acute infection
phase [11].
Regulatory T cells (Tregs), characterized by expression
of the transcription factor forkhead box P3 (Foxp3), play a
key role in the maintenance of immunological tolerance
and prevent immunopathology [12-17]. However, in viral
diseases Tregs can exhibit both beneficial effects by redu-
cing immune-mediated tissue damage and detrimental ef-
fects due to their immunosuppressive properties, causing
disease exacerbation or viral persistence, respectively. Re-
cently, rapid expansion of Tregs associated with an in-
creased expression of the immunosuppressive cytokine
IL-10 has been demonstrated in the brain of susceptible
SJL mice but not in resistant C57BL/6 mice following
TMEV infection [11,18]. Moreover, functional inactivation
of Tregs by anti-CD25 antibodies prior to infection results
in an enhanced virus-specific immunity, reduced viral
load, and delayed disease progression, while the adoptive
transfer of Tregs leads to disease exacerbation in TMEV-
infected SJL mice [11,19]. However, these treatments have
failed to influence the disease course in resistant mice
strains (C57BL/6), demonstrating the complexity of pro-
tective immune responses in infectious CNS disorders.
In order to obtain further insights into the relevance
of Tregs for disease resistance and antiviral immunity in
TME, the kinetics of CNS-infiltrating immune cells and
the underlying chemokine and cytokine expression fol-




BAC-transgenic DEREG mice have been described previ-
ously [20]. All animals were gender matched and controlmice used in our experiments were non-transgenic litter-
mates obtained from DEREG breeding. Mice were bred
and maintained under specific pathogen-free condition in
our animal facilities. All animals used in experiments were
8 weeks of age. The animal experiments were approved
and authorized by the local authorities (Niedersächsisches
Landesamt für Verbraucherschutz- und Lebensmittelsi-
cherheit (LAVES), Oldenburg, Germany, permission num-
ber 33.12-42502-04-10/0150) and performed according
to international guidelines on the use of laboratory ani-
mals [21].
DT treatment
DEREG and WT control mice received 1 μg of diphtheria
toxin (DT) intraperitoneally (ip) (Calbiochem, San Diego,
CA, USA) in 100 μl PBS on days −2 and −1 corresponding
to the infection.
Intracerebral injection
Eight-week-old male DEREG mice and non-transgenic lit-
termate controls were inoculated into the right hemi-
sphere with 1.63 × 106 plaque-forming units/mouse of the
BeAn strain of TMEV in 20 μl DMEM (PAA Laboratories,
Cölbe, Germany) with 2% fetal calf serum and 50 μg/kg
gentamicin. Inoculation was carried out under general
anesthesia with medetomidine (0.5 mg/kg, Domitor, Pfizer,
Karlsruhe, Germany) and ketamine (100 mg/kg, ketamine
10%, WDT eG, Garbsen, Germany).
Isolation of cells from brain
Mice were transcardially perfused with PBS and the brains
were carefully dissected and collected in Hank’s balanced
salt solution containing 15 mM HEPES and 5% glucose.
The brain was cut into small pieces and digestion was car-
ried out by incubating the tissue fragments in DMEM
containing 0.5 mg/ml collagenase D (Roche, Mannheim,
Germany) and 10 μg/ml DNase I (Roche, Mannheim,
Germany) in an orbital shaker at 80 rpm for 30 minutes at
37°C. Tissue suspensions were then passed through a 70-
μm mesh, pelleted, resuspended in a 40% isotonic Percoll
solution (GE Healthcare, Uppsala, Sweden), and layered
over 70% isotonic Percoll solution. After centrifugation at
2,100 rpm for 30 minutes at room temperature, the upper
myelin layer was aspirated and the cells at the interface
were collected, washed once with PBS and then used for
further analyses.
Antibodies and reagents
Fluorochrome conjugated antibodies specific for mouse,
anti-CD3 (clone: 145-2C11), anti-CD4 (clone: RM4-5),
anti-Foxp3 (clone: MF-14), anti-IFNγ (clone: XMG1.2)
and anti-IL-17A (clone: TC11-18H10.1) were all pur-
chased from Biolegend, San Diego, CA, USA. Anti-CD8
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Germany.
Flow cytometry
For cell surface staining, cells were preincubated with
CD16/32 Fc-block antibody (clone: 93, eBioscience,
Frankfurt, Germany) at room temperature (RT) for 10 mi-
nutes, and subsequently incubated with the indicated con-
jugated antibody cocktail for 30 minutes in a total volume
of 100 μl of PBS containing 1% FBS. For live/dead stain-
ing, cells were incubated in fixable viability dye eFluor®
506 (1:1,000 dilution; eBioscience, Frankfurt, Germany) at
4°C for 30 minutes. For intracellular cytokine staining,
cells were restimulated for 6 hours in complete DMEM
(Gibco, Darmstard, Germany) in the presence of 50 ng/ml
phorbol 12-myristate 13-acetate and 500 ng/ml ionomycin
(both from Sigma-Aldrich, St. Louis, MO, USA). For the
last 4 hours, brefeldin A (10 μg/ml; Sigma-Aldrich, St.
Louis, MO, USA) was added to the cultures. Intracellular
staining/transcription factor was performed using Foxp3
staining buffer set (eBioscience, Frankfurt, Germany) ac-
cording to the manufacturers’ recommendations. Samples
were acquired on LSR II (BD Biosciences, San Jose, CA,




For histology and immunohistochemistry the cerebrum
was fixed in 10% formalin for 24 hours, embedded in par-
affin wax and stained with H & E. Inflammatory responses
were graded based upon the degree of perivascular infil-
trates (PVI) using a semiquantitative scoring system: 1 = 1
to 25 cells (mild); 2 = 26 to 50 cells (moderate); 3 = >50
cells per high power field (severe) as previously described
[22]. Immunohistochemistry was performed using a
polyclonal rabbit anti-CD3 antibody (DakoCytomation,
Hamburg, Germany) for the detection of T cells. For
blocking of the endogenous peroxidase, formalin-fixed,
paraffin-embedded tissue sections were treated with 0.5%
H2O2 diluted in methanol for 30 minutes at RT. Antigen
retrieval was done by heating the sections in 10 mM
Na-citrate buffer pH 6.0 for 20 minutes in a microwave
oven (800 W). Subsequently, slides were incubated with
the respective primary antibody overnight at 4°C. Biotinyl-
ated goat-anti-rabbit IgG diluted 1:200 (Vector Labora-
tories, Burlingame, CA, USA) was used as a secondary
antibody. Sections used as negative controls for CD3
immunohistochemistry were incubated with rabbit normal
serum at a dilution of 1:2,000 (Sigma-Aldrich Chemie
GmbH, Taufkirchen, Germany). Slides were subsequently
incubated with the peroxidase-conjugated avidin-biotin
complex (ABC method, Vector Laboratories, Burlingame,
CA, USA) for 30 minutes at RT. After the positiveantigen-antibody reaction visualization by incubation
with 3.3-diaminobenzidine-tetrachloride (DAB) in 0.1 M
imidazole, sections were counterstained with Mayer’s
hematoxylin.
For immunofluorescence staining, antigen retrieval was
performed as mentioned above, following which the sec-
tions were blocked with 10% normal donkey serum. Slides
were incubated with primary anti-IL10 (clone: M-18:
Santa Cruz Biotechnology, Santa Cruz, CA, USA) along
with anti-CD3, anti-glial fibrillary acidic protein (GFAP)
(DakoCytomation, Hamburg, Germany) or anti-Iba1
(Wako, Osaka, Japan) antibodies for 2 hours at RT and
after thorough washing the slides were incubated with
fluorochrome conjugated secondary donkey anti-goat
antibodies for 1 hour.
The density of positive cells/mm2 in the cerebral neuro-
parenchyma was manually counted in randomly selected
cerebral areas with a 40-fold objective and a 10-fold cali-
brated eyepiece reticule (Olympus Europe, Hamburg,
Germany).RNA isolation
RNA was isolated from 10 to 40 mg tissue of each fro-
zen brain using an Omni’s PCR Tissue Homogenizing
Kit (Süd-Laborbedarf GmbH, Gauting, Germany) and
RNeasy® Lipid Tissue Mini Kit (#74804; Qiagen GmbH,
Hilden, Germany).Reverse transcription-polymerase chain reaction (RT-PCR)
Equal amounts of RNA were subsequently transcribed
into cDNA with the High Capacity cDNA Reverse
Transcription Kit with RNase Inhibitor (#4374966;
Applied Biosystems®; Life Technologies GmbH, Darmstadt,
Germany). RT-PCR for the quantification of TMEV (for-
ward primer: 5′-GACTAATCAGAGGAACGTCAGC-3′;
reverse primer: 5′-GTGAAGAGCGGCAAGTGAGA-3′)
and three housekeeping genes: glyceraldehyde 3-phosphate
dehydrogenase (GAPDH; forward primer: 5′-GAGGC
CGGTGCTGAGTATGT-3′; reverse primer: 5′-GGTG
GCAGTGATGGCATGGA-3′), β-actin (forward primer:
5′-GGCTACAGCTTCACCACCAC-3′; reverse primer:
5′-ATGCCACAGGATTCCATACC-3′), hypoxanthine-
guanine phosphoribosyltransferase (HPRT; forward primer:
5′-GGACCTCTCGAAGTGTTGGA-3′; reverse primer:
5′-TTGCGCTCATCTTAGGCTTT-3′) in brain tissues
was performed using the Mx3005P™ Multiplex Quanti-
tative PCR System (Agilent Technologies Deutschland
GmbH, Böblingen, Germany) and SYBR® Green I as
DNA-binding dye as described [23,24]. Ten-fold serial
dilution standards ranging from 108 to 102 copies/μl
were used to quantify the results. A normalization factor
achieved from the three housekeeping genes was calcu-
lated using the geNorm software version 3.4 to correct for
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was controlled by melting curve analysis.
For other gene expression analysis, quantitative real-time
PCR was performed using the StepOne™ Real-Time PCR
System and appropriate TaqMan probes (Applied Biosys-
tems, Life Technologies GmbH, Darmstadt, Germany,
Additional file 1: Table S1). The ΔΔCt method was applied
to determine differences in the expression of CCL2,
CXCL10, interleukin-6 (IL-6), interleukin-10 (IL-10), infer-
feron-γ (IFNγ), tumor necrosis factor-α (TNF-α) and indu-
cible NO synthase (NOS2) and granulocyte-macrophage
colony stimulating factor (GM-CSF) between uninfected
and TMEV-infected animals that were previously treated
with PBS or DT. Changes in mRNA expression levels were
calculated after normalization to the arithmetic mean of
HPRT and GAPDH.
Statistical analysis
All statistical analyses were conducted using GraphPad
Prism 5.0 (GraphPad Software, La Jolla, CA, USA). All
data are expressed as group mean ± SD unless otherwise
stated. The data generated from several mice from each
group was analyzed using Student’s t-test. Results were
considered statistically significant at P <0.05.
Results
Treg depletion prior to TMEV infection enhances the
infiltration of T cells into the brain
In our initial attempts we assessed the outcome of Treg
depletion on the acute response to TMEV infection. For
this we employed the strategy of depleting Foxp3+ Treg
prior to TMEV infection by ip administration of DT into
DEREG mice, which express the DT receptor under the
control of the foxp3 locus [20]. Analysis of blood 1 day
after DT injection revealed that most of the Foxp3+ CD4+
T cells were depleted from circulation (Additional file 2:
Figure S1). Following intracerebral inoculation of the
BeAn strain of TMEV into Treg-depleted and non-
depleted mice, the inflammatory response and virus load
were assessed. Histology revealed no differences in the de-
gree of neuroinflammation between Treg-depleted and
non-depleted mice (data not shown). Interestingly, despite
the similar severity of encephalitis among the groups, we
observed in immunohistochemistry a significantly higher
number of CD3+ T cells in the cerebrum of Treg-depleted
mice at 3 days post inoculation (dpi) “However, this differ-
ence in the number of T cells was transient and was not
observed at 7 dpi (Figure 1A and B). Such differences were
not evident among PBS- and DT-treated wild type (WT)
littermate controls at these time points, thus confirming
that transient increase in the number of T cells was the re-
sult of Treg depletion (Additional file 3: Figure S2A).
These results suggest that Tregs might regulate the early
recruitment of effector T cells to the sites of infection.Predominantly IFNγ-producing T cells infiltrate into the
brain
Our next attempt was to assess the effect of Treg deple-
tion on the antiviral immune response in the CNS. IFNγ
is a prominent effector molecule in antiviral immune
defense and produced mainly by effector lymphocyte pop-
ulations. Measuring the gene expression in infected brains
by RT-PCR, we found, at 3 dpi, a 2-fold higher expression
of IFNγ in Treg-depleted mice compared to non-depleted
mice. No such differences in the expression of IFNγ were
observed at 7 dpi between the two groups (Figure 2A).
This coincides with the above mentioned observation
where we found a transient increase of T cells at 3 dpi in
the absence of Tregs. Therefore, we sought to isolate im-
mune cells from the brain of infected mice and analyze
the T cell subpopulations in terms of their effector
cytokine secretion profile. At 3 dpi, only few T cells
were detected among the cells harvested from the brain
of mice with an unaltered Treg compartment. Upon Treg
depletion prior to infection there was an increased infiltra-
tion of T cells as we observed an increased frequency of
CD4+ and CD8+ T cells in the brain (Additional file 4:
Figure S3). Further supporting our RT-PCR data, flow
cytometric analysis revealed a significantly higher percent-
age of IFNγ-producing Th1 and CD8+ T cells among the
cells isolated from the brain of Treg-depleted mice at 3
dpi but not at 7 dpi (Figure 2B and C). No IL-17-
producing CD4+ Th17 cells were found at both time
points analyzed, regardless of the Treg status (Figure 2B).
It is noteworthy that frequencies of IFNγ-producing T
cells in the spleen of Treg-depleted mice were significantly
higher at 3 dpi and only marginally higher at 7 dpi com-
pared to non-depleted mice (Additional file 5: Figure S4).
Further, we could confirm that the observed effects were
only due to Treg depletion in DEREG mice, as no such
differences were observed in DT-treated WT littermate
controls (Additional file 3: Figure S2B-E). Taken together,
these results suggest that a strong IFNγ-producing T cell
response is primed in the periphery in the absence of
Tregs and this might lead to an early recruitment of these
effector T cells into the brain.
Depletion of Tregs prior to infection does not influence
viral clearance in DEREG mice
Since we observed a higher frequency of IFNγ-producing
CD4+ and CD8+ T cells infiltrating into the brain of
TMEV-infected mice in the absence of Tregs at 3 dpi, we
expected an enhanced and faster viral clearance in Treg-
depleted mice. Therefore, we sought to assess the viral
load by RT-PCR in the brain at 3 dpi and 7 dpi. Signifi-
cantly lower copy numbers of viral RNA were detected at
7 dpi compared to 3 dpi, indicating a potent antiviral re-
sponse in TMEV-infected mice. However, it appears that
Treg depletion had no impact on the antiviral response as
Figure 1 Early recruitment of T cells into Theiler’s murine encephalomyelitis virus (TMEV)-infected brain in the absence of Tregs.
Following intraperitoneal administration of PBS or diphtheria toxin (DT), DEREG mice were intracerebrally infected with TMEV. (A) Immunohistochemistry of
TMEV infected brains at 3 days post inoculation (dpi) (left panel) and 7 dpi (right panel) reveals higher numbers of CD3+ T cells only at 3 dpi in DT-treated
mice (lower panel) compared to PBS-treated mice (upper panel). (B) Quantification of CD3+ T cells in the cerebral neuroparenchyma of 6 to 8 infected
mice reveals a significantly increased number on T cells in DT-treated mice at 3 dpi. Box and whisker plots display median and quartiles with maximum
and minimum values. *P-value <0.05.
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viral load between Treg-depleted and non-depleted mice
neither at 3 dpi nor at 7 dpi (Figure 3).
Treg depletion did not alter the expression of
inflammatory mediators in the brain
It was rather puzzling to have an increased frequency of
IFNγ+ T cells and yet not to observe any difference in the
viral load or tissue damage. Therefore, we studied the local
inflammatory response triggered by TMEV infection in
the absence of Tregs. We compared gene expression of
certain inflammatory mediators in response to TMEV in-
fection in the brain of Treg-depleted and non-depletedmice. Chemokines CCL2 and CXCL10, believed to be pro-
duced by resident glial cells and known to play a major
role in the recruitment of monocytes and T cells from the
periphery, were strongly induced upon TMEV infection
(Figure 4A and B). Nevertheless, depletion of Tregs had
no influence on their expression both at 3 dpi and 7 dpi.
Similarly, a potent pro-inflammatory response was in-
duced upon TMEV infection characterized by significantly
increased expression of GM-CSF, IL-6, TNF-α, and NOS2
in these mice compared to uninfected controls. However,
we did not detect any significant difference in the tran-
scription of these genes between Treg-depleted and non-
depleted mice (Figure 4A and B).
Figure 2 Increased frequency of IFNγ-producing T cells found in the brain tissue of Treg-depleted mice post Theiler’s murine
encephalomyelitis virus (TMEV) infection. (A) RT-PCR of mRNA isolated from the brain of TMEV-infected DEREG mice treated with PBS or
diphtheria toxin (DT) show an approximately 2-fold higher expression of IFNγ in Treg-depleted (DT) mice compared to non-depleted mice (PBS)
at 3 days post inoculation (dpi). However, no significant difference can be observed at 7 dpi. The graph represents mean ± SD of the data obtained
from four infected mice from each group. (B) Flow cytometry analysis of cells isolated from infected brains show a higher frequency of IFNγ-producing
T cells CD4+ (upper panel) and CD8+ (lower panel) T cells at 3 dpi (left panel) and not at 7 dpi (right panel). No IL-17-producing cells were found in
any of the groups. Data obtained by analyzing the CD3+CD4+ (C) and CD3+CD8+ cells (D) from 7 to 9 infected mice from each group is shown in this
plot. *P-value <0.05, **P-value <0.01.
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for the lack of Tregs
Another interesting observation from the RT-PCR ana-
lysis was that the expression of the anti-inflammatory
cytokine IL-10 in the brain of infected mice was
unaffected despite of Treg-depletion. The amount of
IL-10 expressed was similar in Treg-depleted and non-
depleted mice both at 3 dpi and 7 dpi (Figure 5A).
However, expression of IL-10 was increased by few
folds at 7 dpi, suggesting a role of locally produced
IL-10 in neuroprotection. In an attempt to delineate
the source of IL-10 we performed immunofluorescence
co-stainings of 7 dpi brain sections [18]. We foundthat the majority of IL-10 signals co-localized with
Iba-1+ cells, indicating that microglia or infiltrating
macrophages could be the source of IL-10 (Figure 5B).
At the same time IL-10 was found lacking among the
majority of CD3+ T cells and GFAP+ astrocytes. How-
ever, we failed to detect any significant difference in
the number of Iba1+ IL-10+ cells between PBS- and
DT-treated groups at this time point (data not shown).
Taken together these results suggest that IL-10 pro-
duced by microglia/macrophages compensates for the
lack of Tregs and might limit the extent of tissue
damage resulting from increased infiltration of effector
T cells.
Figure 3 Treg depletion has no impact on viral clearance.
Viral load in the infected brain was determined by quantification of
Theiler’s murine encephalomyelitis virus (TMEV) RNA by RT-PCR. No
significant differences in viral RNA copy numbers between
Treg-depleted (diphtheria toxin; DT) or non-depleted mice (PBS)
was observed either at 3 days post inoculation (dpi) or 7 dpi. In either
case, the virus was efficiently eliminated as demonstrated by
significantly lower number of viral RNA transcripts at 7 dpi. Five
mice from each group were analyzed. Box and whisker plots display
median and quartiles with maximum and minimum values.
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In this study, we investigated the role of Foxp3+ Tregs
during an acute viral infection in the CNS using DEREG
mice in which Tregs can be selectively depleted by inject-
ing DT. Our findings support the hypothesis that Tregs
have no major influence in regulating immune responses
against TMEV in the CNS of resistant C57BL/6 mice.
However, this does not reflect an altogether null effect of
Treg depletion as we did observe a transient increase in
the number of effector Th1 and CD8+ T cells in the brain
at an early stage of infection.
TME is a good model to study the pathogenesis of
virus-mediated demyelinating diseases. In response to
TMEV infection, CD4+ and CD8+ T cells are primed inFigure 4 Expression of pro-inflammatory mediators is unaffected by
expression of selected pro-inflammatory mediators (CCL2, CXCL10, GM-CSF, T
toxin; DT) and non-depleted (PBS) TMEV-infected mice at 3 days post inocula
by using ΔΔCt method (normalizing the ΔCt values obtained from infected m
of fold change in gene expression obtained by analyzing four mice from eachthe periphery, which subsequently infiltrate into the CNS
and mount antiviral immune responses, leading to effect-
ive viral clearance within the first weeks of infection in re-
sistant C57BL/6 mice. On the contrary, susceptible SJL
mice show an inadequate viral clearance, which causes
virus persistence and chronic demyelination [26,27]. One
of several factors contributing to this phenomenon in SJL
mice is the suppressive activity of infiltrating Tregs in the
CNS together with insufficient effector CD8+ T cell re-
sponses [11,28]. It has been demonstrated that functional
inactivation of Tregs prior to TMEV infection enhances
viral clearance by augmenting CD8+ T cells, Th1 cells and
antibody responses leading to delayed disease onset and
progression [11]. These results suggest that Tregs lead to
TMEV persistence by suppressing antiviral responses in
mice with a susceptible background. On the other side,
while inhibiting effector T cell function, Tregs eventually
limit CNS inflammation and tissue damage. It has been
shown by a previous study that Treg depletion prior to
EAE induction increases disease severity [29]. Therefore,
we intended to study the role of Tregs in resistant C57BL/
6 mice, which mount an efficient TMEV-specific immun-
ity. Interestingly, at 3 dpi we observed a significantly
higher frequency of IFNγ-producing CD4+ and CD8+ T
cells in the brain in the absence of Tregs. In contrast to
findings in SJL mice, we did not observe any differences in
the viral load between Treg-depleted and non-depleted
mice suggesting that the anti-TMEV response in C57BL/6
mice is unaffected by the presence or absence of Tregs.
This is in line with a recent report that used an alternative
approach of adoptive transfer of in vitro-induced Tregs
(iTreg) and found that early iTreg treatment exacerbated
TMEV-induced demyelination in SJL mice while C57BL/6
mice were largely unaffected by such treatments [19]. In
C57BL/6 mice, TMEV infection results in rapid expansionTreg depletion. To study the local inflammatory response the gene
NF-α, IL-6 and NOS2) was compared between Treg-depleted (diphtheria
tion (dpi) (A) and 7 dpi (B) by RT-PCR. Fold changes (RQ) was calculated
ice to that of uninfected controls). The bar graphs represent mean ± SD
group.
Figure 5 Locally produced IL-10 might be responsible for anti-inflammatory response. (A) IL-10 gene expression at 3 days post inoculation
(dpi) and 7 dpi in Treg-depleted (diphtheria toxin; DT) and non-depleted (PBS) mice was assessed by RT-PCR. The bar graphs represent mean ± SD of
fold change in gene expression obtained by analyzing four mice from each group. (B) Double-immunofluorescence stainings of coronal brain sections
using antibodies against IL-10 (red) in combination with Iba-1 (microglia), glial fibrillary acidic protein (GFAP) (astrocytes) or CD3+ (T cells) at 7 dpi in
Treg-depleted mice show that microglia are the major source of IL-10.
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clearing the virus [26]. Therefore, it might not be surpris-
ing that a mere increase in T cell numbers would lead to
significant differences in viral load. It should be noted that
the CNS has a limited regenerative capacity and hence an
unwarranted inflammation triggered by immune cells in-
filtrating from the periphery might result in CNS tissue
damage. Early studies have shown that an increase in pro-
inflammatory Th1 responses enhances the development of
demyelinating disease in resistant as well as in susceptible
mice following TMEV infection [30,31]. Hence, we ex-
pected that a heightened IFNγ response in the brain
would trigger a stronger inflammatory response and cause
more severe tissue damage. However, we neither observed
early clinical signs in any of the groups nor any differences
in the degree of tissue damage between Treg-depleted and
non-depleted mice. This, we believe, is due to the fact that
the inflammatory response in the brain is largely unaltered
despite Treg depletion. Accordingly, the pro-inflammatory
factors TNF-α, GM-CSF, IL-6 and NOS2 displayed similarexpression levels in mice with unaltered or reduced
amounts of Tregs in response to TMEV. Another strik-
ing observation was that the expression of the anti-
inflammatory cytokine IL-10 was unaffected despite Treg
depletion. This is interesting considering the fact that
Tregs are an important source of IL-10 during CNS in-
flammation [29]. A recent study demonstrated that the ex-
pression of IL-10 during TMEV infection is mostly
restricted to T cells; however, a portion of macrophages/
microglia also contributes to IL-10 expression in the brain
of acutely TMEV-infected mice [18]. We observed expres-
sion of IL-10 as early as at 3 dpi and was further increased
at 7 dpi regardless of the presence or absence of Tregs. It
is known that IL-10 has a dampening effect on inflamma-
tory responses and plays a major role in inducing anti-
inflammatory mechanisms in the brain [19]. In C57BL/6
mice, resident glial cells, especially M2-type microglia/
macrophages, by producing IL-10 either in response to
virus or due to heightened inflammatory response, might
compensate for the lack of Tregs. Hence, we did not
Prajeeth et al. Journal of Neuroinflammation 2014, 11:180 Page 9 of 10
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that infiltrate into the brain.
In conclusion, we could confirm that resistance to
TMEV infection in C57BL/6 mice is largely due to the in-
duction of effective CD4+ and CD8+ T cell responses,
which is not influenced by Treg depletion. Furthermore,
sustained expression of IL-10, mainly by resident glial cells
during early infection, might limit the extent of damage
caused by an unwanted immune response in the brain.
While we believe that regulation by Tregs is strain-
dependent, a significant role of local anti-inflammatory
cytokines like IL-10 in neuroprotection during acute
viral infections of the CNS cannot be ignored.Additional files
Additional file 1: Table S1. Taqman probes used for RT-PCR analysis.
Additional file 2: Figure S1. Depletion efficiency in DEREG mice post
DT treatment. Wild type (WT) and DEREG mice were treated ip with two
doses of 1 μg/ml of DT or with PBS alone on consecutive days. One day
later, percentage of CD4+ Foxp3+ cells in the blood was determined by
flow cytometry. The majority of Tregs were depleted in DEREG mice
treated with DT whereas Tregs in WT mice were unaffected. Six mice
were analyzed from each group. ***P-value <0.001.
Additional file 3: Figure S2. Diphtheria toxin administration in to WT
mice has no obvious effects. In parallel to DEREG infection, non-transgenic
littermates (WT) treated with PBS and DT were infected with TMEV to test
the off-target effects of DT. (A) Immunohistochemistry of coronal brain
sections at 3 dpi (left panel) and 7 dpi (right panel) to detect CD3+ T cells
showed no differences between PBS- and DT-treated mice. Box and whisker
plots display median and quartiles with maximum and minimum values.
(B-E) Flow cytometric analysis of cells isolated form the brain and spleen of
WT mice at 3 dpi (B and C) and 7 dpi (D and E) to determine the frequency
of IFNγ-producing CD4+ T cells (B and D) and CD8+ T cells (C and E). No
significant differences were observed between PBS- and DT-treated mice.
Each dot in the scatter plot represents the data from an individual mouse.
Additional file 4: Figure S3. A transient increase in the frequency of
CD4+ and CD8+ T cells post TMEV infection in Treg-depleted mice. Flow
cytometric analysis of cells isolated from the brain of Treg-depleted (DT)
and non-depleted (PBS) mice at 3 dpi and 7 dpi show higher frequency
of CD4+ and CD8+ T cells among living cells at 3 dpi in Treg-depleted
mice. ***P-value <0.001.
Additional file 5: Figure S4. Effector T cells were efficiently primed in
the periphery in response to TMEV infection following Treg ablation.
Percentage of IFNγ-producing CD4+ and CD8+ T cells in the spleen was
compared between non-depleted and Treg-depleted mice at 3 dpi and
7 dpi. *P-value <0.05, ***P-value <0.001.
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